Trade

with

Compugen Ltd
(NASDAQ: CGEN)
AdChoices
7.67
-0.16
-2.04%
After Hours :
-
-
-

Open

7.74

Previous Close

7.83

Volume (Avg)

65.93k (103.40k)

Day's Range

7.64-7.88

52Wk Range

7.20-14.32

Market Cap.

371.75M

Dividend Rate ( Yield )

-

Beta

1.40

Shares Outstanding

48.47M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 3.55M

    • Net Income

    • -14.08M

    • Market Cap.

    • 371.75M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -159.30

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.40

    • Forward P/E

    • -

    • Price/Sales

    • 45.05

    • Price/Book Value

    • 3.87

    • Price/Cash flow

    • -49.26

      • EBITDA

      • -16.67M

      • Return on Capital %

      • -14.99

      • Return on Equity %

      • -20.00

      • Return on Assets %

      • -14.99

      • Book Value/Share

      • 2.02

      • Shares Outstanding

      • 48.47M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 6.60

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8,827.30

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 60.04

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 47.86

            • 82.75

            • Pre-Tax Margin

            • -151.80

            • 39.38

            • Net Profit Margin

            • -159.30

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 14.56

              • 2.92

              • Quick Ratio

              • 14.56

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.26

              • 2.21

              • Book Value/Share

              • 2.02

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -28.33

                • 277.78

                • P/E Ratio 5-Year High

                • -51.78

                • 634.30

                • P/E Ratio 5-Year Low

                • -8.32

                • 124.82

                • Price/Sales Ratio

                • 45.05

                • 9.35

                • Price/Book Value

                • 3.87

                • 8.50

                • Price/Cash Flow Ratio

                • -49.26

                • 50.25

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -20.00

                        (-45.30)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -14.99

                        (-31.10)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -20.00

                        (-45.90)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.09

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -17.04M
                      Operating Margin
                      -480.22
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -49.26
                      Ownership

                      Institutional Ownership

                      10.35%

                      Top 10 Institutions

                      7.08%

                      Mutual Fund Ownership

                      4.67%

                      Float

                      95.51%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Yelin Lapidot Equity

                      •  

                        172,045

                      • 0.00

                      • 0.35

                      • I.B.I Tel Aviv 75 Basket

                      •  

                        165,200

                      • -4.99

                      • 0.34

                      • Yelin Lapidot YETER

                      •  

                        162,663

                      • 0.00

                      • 0.33

                      • DFA International Small Company Port

                      •  

                        143,885

                      • 10.94

                      • 0.29

                      • Danske Invest Europe Absolute

                      •  

                        119,000

                      • 0.00

                      • 0.24

                      • Migdal Biomed

                      •  

                        101,570

                      • -19.29

                      • 0.21

                      • Harel Selected BioMed

                      •  

                        101,450

                      • -6.93

                      • 0.21

                      • Migdal Tel Aviv 75 Tracker

                      •  

                        87,690

                      • -5.18

                      • 0.18

                      • Yelin Lapidot Flexible Focus

                      •  

                        81,595

                      • 0.00

                      • 0.17

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Morgan Stanley Smith Barney LLC

                      •  

                        597,925

                      • +1.25%

                      • 1.23

                      • Yelin Lapidot Mutual Funds Mgmt Ltd

                      •  

                        592,630

                      • 0.00%

                      • 1.21

                      • ClearBridge Advisors, LLC

                      •  

                        481,639

                      • -2.35%

                      • 0.99

                      • Rothschild Investment Corp

                      •  

                        423,055

                      • +1.21%

                      • 0.87

                      • Migdal Mutual Funds Ltd.

                      •  

                        308,188

                      • -8.42%

                      • 0.63

                      • Blair William & Co

                      •  

                        198,450

                      • +3.05%

                      • 0.41

                      • I.B.I Mutual Funds Management (1978) Ltd

                      •  

                        188,258

                      • -3.99%

                      • 0.38

                      • Janney Montgomery Scott LLC

                      •  

                        165,212

                      • -4.72%

                      • 0.34

                      • Dimensional Fund Advisors LP

                      •  

                        161,376

                      • +11.16%

                      • 0.33

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Compugen, Ltd., was incorporated on February 10, 1993 as an Israeli corporation. The Company and its subsidiary is a therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important...more unmet needs in the fields of immunology and oncology. Its business model involves early-stage collaborations covering the further development and commercialization of its discovered product candidates and various forms of research and discovery agreements, in both cases providing with potential fees, research revenues, milestones, royalties and other revenue sharing payments. Oncology and immunology are both areas of complex and challenging diseases with unmet medical needs. Its science-driven predictive capabilities are well suited for the identification of novel thera...morepeutic candidates for these complex, multi-factorial and challenging therapeutic fields. The Company’s discovery efforts are based on systematic and continuously improving in silico (by computer) product candidate prediction and selection followed by experimental validation, with selected product candidates being advanced in its Pipeline Program. Its silico predictive models utilize a broad and continuously growing infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities. The Company’s infrastructure development efforts was the creation of its three key infrastructure platforms, LEADS, MED and NexGen, which integrate its scientific understandings and predictive models. LEADS provides a predictive view of the human transcriptome and proteome and enables the discovery of novel genes and proteins. MED provides analysis of the expression levels of genes across a variety of tissues and disease states, and NexGen is designed to efficiently and accurately integrate and analyze a vast amount of Next Generation Sequencing data. As of January 1, 2014, the company has a total of 43 issued and allowed patents, of which 32 are U.S. patents, five are Australian patents, three are Israeli patents, two are European patents and one is a Japanese patent. The Company’s competitors include biotechnology companies, the research and discovery groups of pharma companies, academic and research institutions and governmental and other publicly funded agencies. The Company is subject to the laws and regulations in the U.S. and Israel governing the use, storage, handling and disposal of all these materials and resulting waste products.lessless

                      Key People

                      Anat Cohen Dayag,PhD

                      CEO/President/Director

                      Martin S. Gerstel

                      Chairman of the Board/Director

                      Dikla Czaczkes Axselbrad

                      CFO

                      Dr. John Hunter, Ph.D

                      Vice President, Divisional

                      Arie Ovadia,PhD

                      Director

                      • Compugen Ltd

                      • 72 Pinchas Rosen Street

                      • Tel Aviv, 69512

                      • ISR.Map

                      • Phone: +972 37658585

                      • Fax: +972 37658555

                      • cgen.com

                      Incorporated

                      1993

                      Employees

                      57

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: